Recce Pharmaceuticals

Recce Pharmaceuticals Tangible Book Value per Share

The Tangible Book Value per Share of Recce Pharmaceuticals (RCE.AX) as of Oct 17, 2026 is -0.06 AUD. In the previous year, Tangible Book Value per Share was -0.01 AUD — a change of 447.93% (lower).

Tangible Book Value per Share

-0.06AUD

YoY

447.93%

Last updated:

Tangible Book Value per Share of Recce Pharmaceuticals is 2026 -0.06 AUD. Tangible Book Value per Share of Recce Pharmaceuticals was 2025 -0.01 AUD. It decreases by 447.93% lower compared to the previous year.

The Recce Pharmaceuticals Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2019
-0.00 AUD
Jan 1, 2020
0.01 AUD
Jan 1, 2021
0.07 AUD
Jan 1, 2022
0.03 AUD
Jan 1, 2023
-0.01 AUD
Jan 1, 2024
-0.03 AUD
Jan 1, 2025
-0.01 AUD
Jan 1, 2026
-0.06 AUD
The Recce Pharmaceuticals Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
-0.06AUD+447.93%
-0.01AUD-67.95%
-0.03AUD+267.88%
-0.01AUD-125.73%
0.03AUD-50.93%
0.07AUD+786.62%
0.01AUD-670.16%
-0.00AUD-158.37%
0.00AUD+17.75%
0.00AUD-83.20%
0.01AUD-25.46%
0.02AUD-8,487.60%
-0.00AUD-83.81%
-0.00AUD-400.00%
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Recce Pharmaceuticals Stock analysis

What does Recce Pharmaceuticals do? Recce Pharmaceuticals Ltd, headquartered in Sydney, Australia, operates in the Health Care sector, focusing on the research and development of pharmaceutical drugs targeting infectious diseases. The company develops anti-infective therapies, including RECCE 327 for intravenous and topical use against serious bacterial infections, RECCE 435 as an oral treatment, and RECCE 529 for viral infections. All compounds are water-soluble across all pH levels, leveraging multi-layered mechanisms to combat bacterial and viral mutations. Recce Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Recce Pharmaceuticals stock

Tangible Book Value per Share of Recce Pharmaceuticals is -0.06 AUD in 2026.

Tangible Book Value per Share of Recce Pharmaceuticals changed from -0.01 AUD to -0.06 AUD, representing a 447.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Recce Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Recce Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Recce Pharmaceuticals